Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dactavira (EGCG/Sofosbuvir/Daclatasvir) in HCV Genotype 4
NCT03186313Phase 3Completed
- Sponsor
- Egyptian Liver Hospital
- Start
- Sep 2016
- Primary completion
- May 2017
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epigallocatechin gallate in hepatitis C virus infection, sponsored by Egyptian Liver Hospital. Started Sep 2016; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03186313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186313.